Alkylator Score and Leukemia in Childhood Cancer Survivors

Purpose: To identify a patient with a history of childhood cancer who is at increased risk for developing leukemia later in life.

Info MyLikes MyPaths

Evaluation

Are you evaluating a patient who received chemotherapy for childhood cancer?

Yes

Was the patient treated with doxorubicin?

Yes

Was the patient treated with vinca alkaloids?

Yes

Select an appropriate answer for each alkylating agent received

First alkylating agent

Second alkylating agent

Third alkylating agent

Fourth alkylating agent

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Total alkylator score

The risk of developing leukemia based on the alkylator score alone is

Number of factors that will further increase the risk of leukemia

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Criteria For Diagnosis
Complications
- Risk of Lung Cancer Following Therapy for Hodgkin's Disease

Monitoring

Response To Therapy
- Therapy-Related Acute Myeloid Leukemia
- Radiation Exposure | Carcinomas of Kidney & Urinary Tract
Adverse Effects
- Radiation Exposure | Carcinomas of Kidney & Urinary Tract
Disease Progression
- Therapy-Related Acute Myeloid Leukemia
Comorbid Conditions
- Stewart-Treves Syndrome

Specialty

Hematology Oncology

Objective

criteria for diagnosis

ICD-10

C90.1 - Plasma cell leukaemia
C91 - Lymphoid leukaemia
C92 - Myeloid leukaemia
C93 - Monocytic leukaemia
C94 - Other leukaemias of specified cell type
C95 - Leukaemia of unspecified cell type

Info

Purpose: To identify a patient with a history of childhood cancer who is at increased risk for developing leukemia later in life.

Specialty: Hematology Oncology

Objective: criteria for diagnosis

ICD-10: C90.1, C91, C92, C93, C94, C95,

Save Data

Identifier

Enter 1 to 5 characters as ID

Email

Your registered email

Other

Email to

Please separate multiple email IDs with comma (,)

Consult Report

Identifier

Enter 1 to 5 characters as ID

Add to MyPath

Select path

New path